Cargando…
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
BACKGROUND: Aspirin has been found to lower the occurrence rates of some cancers through the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association between aspirin use and the occurrence of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) carriers. However,...
Autores principales: | Liao, Yen-Hsiang, Hsu, Ren-Jun, Wang, Tzu-Hwei, Wu, Chen-Ta, Huang, Sheng-Yao, Hsu, Chung-Y., Su, Yuan-Chih, Hsu, Wen-Lin, Liu, Dai-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953130/ https://www.ncbi.nlm.nih.gov/pubmed/31918672 http://dx.doi.org/10.1186/s12876-020-1158-y |
Ejemplares similares
-
Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study
por: Liao, Yen-Hsiang, et al.
Publicado: (2022) -
Dose escalation (81 Gy) with image-guided radiation therapy and volumetric-modulated arc therapy for localized prostate cancer: A retrospective preliminary result
por: Huang, Sheng-Yao, et al.
Publicado: (2019) -
Androgen deprivation therapy and the risk of subsequent keratitis
por: Liu, Dai-Wei, et al.
Publicado: (2020) -
Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
por: Lee, Chern-Horng, et al.
Publicado: (2023) -
Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
por: Hsu, Ching-Sheng, et al.
Publicado: (2013)